IAPP and diabetes mellitus: Amylin (IAPP), a gluco-modulatory hormone co-expressed with insulin by pancreatic β cells, is downregulated in both T1D and advanced T2D (Abedini et al. 2013), while amylin agonists are considered novel therapeutic agents for treating diabetes (Sonne et al. 2021).